These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Management of axillary hyperhidrosis]. Pomarède N Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S125-8. PubMed ID: 19576478 [TBL] [Abstract][Full Text] [Related]
43. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Vadoud-Seyedi J; Simonart T Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630 [TBL] [Abstract][Full Text] [Related]
44. Unilateral segmental hyperhidrosis. Response to 20% aluminum chloride solution and plastic wrap. Dworin A; Sober AJ Arch Dermatol; 1978 May; 114(5):770-1. PubMed ID: 646401 [TBL] [Abstract][Full Text] [Related]
45. Recalcitrant unilateral infection associated with congenital leg hypertrophy cleared by control of hyperhidrosis. Shelley WB; Shelley ED Cutis; 1984 Mar; 33(3):281-2. PubMed ID: 6723365 [TBL] [Abstract][Full Text] [Related]
46. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Naumann M; Lowe NJ; Kumar CR; Hamm H; Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503 [TBL] [Abstract][Full Text] [Related]
47. Use of a transparent dressing in the treatment of axillary hyperhidrosis with botulinum toxin type A. Galán-Gutiérrez M; Garnacho-Saucedo G; Salido-Vallejo R; Vélez Garcia-Nieto A; Moreno-Giménez JC J Am Acad Dermatol; 2010 Dec; 63(6):e111-2. PubMed ID: 21093655 [No Abstract] [Full Text] [Related]
48. Botulinum toxin injection technique for axillary hyperhidrosis. Del Boz J; Padilla-España L; Segura-Palacios JM Actas Dermosifiliogr; 2014 Jun; 105(5):517-8. PubMed ID: 24468624 [No Abstract] [Full Text] [Related]
49. How to save botulinum toxin A in the treatment of focal axillary hyperhidrosis. Bechara FG; Sand M; Hoffmann K Dermatology; 2006; 213(4):356. PubMed ID: 17135747 [No Abstract] [Full Text] [Related]
51. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Glogau RG Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418 [TBL] [Abstract][Full Text] [Related]
52. Topical atropine sulfate for the treatment of axillary hyperhidrosis. Grimalt R; Domínguez Tordera P; Callejas MA J Cosmet Dermatol; 2006 Dec; 5(4):294-6. PubMed ID: 17716247 [TBL] [Abstract][Full Text] [Related]
53. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414 [TBL] [Abstract][Full Text] [Related]
54. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543 [TBL] [Abstract][Full Text] [Related]
55. Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patients. Marcella S; Goodman G; Cumming S; Foley P; Morgan V Australas J Dermatol; 2011 May; 52(2):123-6. PubMed ID: 21605096 [TBL] [Abstract][Full Text] [Related]
56. A case of hyperhidrosis successfully treated with 20% aluminium chloride hexahydrate in 95% ethyl alcohol. Ganeshmoorthy J; Saravanapavananthan T Singapore Med J; 1990 Feb; 31(1):85-6. PubMed ID: 2333553 [TBL] [Abstract][Full Text] [Related]